Layla review

You cannot find out what a quarter dose costs at Layla, because no milligram figure appears against any price on any page. What you can find is disagreement: the same page prices month-to-month tirzepatide two different ways, and its own FAQ quotes a starting cost matching no card on the site. Give Layla credit for one genuinely useful habit — it prints the pre-discount monthly rate in parentheses beside every first-month offer, so the standing rate sits next to the teaser instead of hiding behind it. Then read the small print, because it costs you. Every plan is badged cancel-anytime while the refund policy on the same page requires thirty days' notice. Canceling costs a non-refundable visit and clinical fee out of your refund. And the all-treatments page stamps the same monthly figure on every row, including the brand-name drugs it cannot apply to.

Vs median

$128/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Standard plan, self-directed low dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Varies by dose, plan or tier

Price last updated

August 2026

Layla does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

Layla sells compounded semaglutide and compounded tirzepatide as weekly injections on monthly and quarterly plans, advertised as all-inclusive of prescription, medication and shipping. Prices are published openly, with the pre-discount monthly rate shown in parentheses beside each first-month offer. Brand-name products are listed on a separate all-treatments page. No milligram figure appears against any price anywhere on the site, and no compounding pharmacy is named.

NOT ONE MILLIGRAM FIGURE APPEARS AGAINST ANY PRICE on /weight-loss or /all-treatments, so what a low dose costs cannot be established before paying

• THREE PRICE BLOCKS ON ONE PAGE DISAGREE. Month-to-month tirzepatide is $449 in one block and $399 in another
• The FAQ on the same page states "The starting cost for GLP-1 medication starts at $1299", a figure that matches no price card on the site
• "CANCEL ANY-TIME" IS BADGED ON EVERY CARD while the refund policy on the same page reads "Subscriptions can be canceled at any time. - Please provide a 30-day notice for cancellation"
• Canceling costs money: "If the order is successfully canceled, a $100 nonrefundable visit and clinical fee will be deducted from your refund"
• On /all-treatments, Wegovy is listed at $1699 and Mounjaro at $1399 while each card is also stamped "$297/mo" — the same field repeated on every row
• Outcome statistics are sourced to "Layla clinical care data of over 1000 patientes over the last 12 months" [sic]
• No compounding pharmacy is named — only "a partner pharmacy"
• States served are not published
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

Layla is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Low dose vs full dose
• What a flat price costs at a low dose
• The true annual cost of a plan